Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 1054-1059

  Leung, Alex Wing Kwan ^a   Chu, Winnie Chiu Wing ^a   Lam, Wynnie Wai Man ^a   Lee, Vincent ^a   Li, Chi Kong ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiac iron overload; Magnetic resonance imaging; T2 star; Thalassaemia

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BETA THALASSEMIA; BIOCHEMISTRY; CHILD; CLINICAL ARTICLE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; ENZYME DEFICIENCY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HEART; HEMOGLOBIN BARTS DISEASE; HEMOGLOBIN E DISEASE; HEMOGLOBIN H DISEASE; HEMOGLOBINOPATHY; HUMAN; IRON CHELATION; IRON OVERLOAD; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PYRUVATE KINASE DEFICIENCY; SCHOOL CHILD; THALASSEMIA MAJOR; TREATMENT DURATION;

ADOLESCENT; ADULT; ANEMIA; BLOOD TRANSFUSION; CHILD; FERRITINS; HEART DISEASES; HUMANS; IRON OVERLOAD; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; YOUNG ADULT;

EID: 71049157652     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22170     Document Type: Article

References (25)

1. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of desferrioxamine in preventing complication of iron overload in patients with thalassaemia major. N Engl J Med 1994;331:567-573.
2. Hahalis G, Alexopoulos D, Kremastinos DT, et al. Heart failure in beta-thalassemia syndromes: A decade of progress. Am J Med 2005;118:957-967. (Pubitemid 41297756)
3. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994;331:574-578. (Pubitemid 24265699)
4. Borgna-Pignatti C, Rugolotto S, Stefano PD, et al. Survival and complications in patients with thalassaemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-1193. (Pubitemid 39390442)
5. Modell B, Khan M, Darlison M. Survival in β-thalassaemia major in the UK: Data from the UK Thalassaemia Register. Lancet 2000; 355:2051-2052. (Pubitemid 30339248)
6. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-1084.
7. Kremastinos DT, Tsetsos GA, Tsiapras DP, et al. Heart failure in beta thalassemia: A 5-year follow-up study. Am J Med 2001;111: 349-354.
8. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179. (Pubitemid 33139463)
9. Mavrogeni SI, Maris T, Gouliamos A, et al. Myocardial iron deposition in b-Thalassemia studied by magnetic resonance imaging. Int J Card Imaging 1998;14:117-122. (Pubitemid 28218930)
10. Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassaemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-547.
11. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol 2007;37:1191-1200. (Pubitemid 350160029)
12. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39. (Pubitemid 36791266)
13. Li CK, Luk CW, Ling SC, et al. Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: Retrospective study. Hong Kong Med J 2002;8:255-260.
14. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355. (Pubitemid 39468951)
15. Davis B, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia. Blood 2000;95:1229-1236. (Pubitemid 30099831)
16. Anderson LJ, Wonke B, Prescott E, et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002;360:516-520. (Pubitemid 35232104)
17. Pennell DJ, Berdoukas V, Karagiorga M, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassaemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-3744.
18. Cohen AR, Galanello R, Piga A, et al. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood 2003;102:1583-1587.
19. Piga A, Galanello R, Forni GL, et al. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally administered iron chelator, in comparison to deferoxamine in thalassaemia patients with transfusional iron overload. Haematologica 2006; 91:873-880.
20. Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 2006;107:3455-3462.
21. Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004;126:736-742. (Pubitemid 39221312)
22. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassaemia and sickle cell disease. Blood 2004;103:1934-1936. (Pubitemid 38268994)
23. Christoforidis A, Haritandi A, Tsatra I, et al. Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with b-thalassaemia major: Comparison between different chelation regimes. Eur J Haematol 2006;78:52-57. (Pubitemid 46018559)
24. Christoforidis A, Haritandi A, Tsitourides I, et al. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassaemia patients. J Pediatr Hematol Oncol 2006;28:311-315. (Pubitemid 43916714)
25. Wood JC, Origa R, Agus A, et al. Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica 2008; 93:917-920. (Pubitemid 351821730)